Company/Division name | Arranta Bio |
Type of work | Manufacturing |
If manufacturing, is the company a contract manufacturer? | Yes |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 500 |
Year reshoring announced: | 2021 |
Year reshoring implemented or to be implemented: | 2022 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 150 |
City reshored to: | Boxborough |
State(s) reshored to: | MA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | biotherapeutic products, microbiome products |
What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training |